Inclusive estimation of complex antigen presentation functions of monocyte-derived dendritic cells differentiated under normoxia and hypoxia conditions

Cancer Immunology, Immunotherapy

Volumn 61, Issue 3, 2012, Pages 409-424

  Ogino, Toshitatsu ^a   Onishi, Hideya ^a   Suzuki, Hiroyuki ^a   Morisaki, Takashi ^b   Tanaka, Masao ^c   Katano, Mitsuo ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b Fukuoka General Cancer Clinic   (Japan)

^c KYUSHU UNIVERSITY   (Japan)

Author keywords

Complex antigen presentation functions; Dendritic cells; Hypoxia; Immunotherapy

Indexed keywords

B7 ANTIGEN; CD83 ANTIGEN; CD86 ANTIGEN; HLA ANTIGEN; HLA DR ANTIGEN; HYPOXIA INDUCIBLE FACTOR 1ALPHA; INTERLEUKIN 4; RNA; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HIF1A PROTEIN, HUMAN; IMMUNOGLOBULIN; LEUKOCYTE ANTIGEN; LIPOPOLYSACCHARIDE; MEMBRANE PROTEIN; OXYGEN;

ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; ARTICLE; CANCER PATIENT; CELL DIFFERENTIATION; CELL MATURATION; CONTROLLED STUDY; DENDRITIC CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; FLUORESCENCE ACTIVATED CELL SORTING; HUMAN; HUMAN CELL; HYPOXIA; IMMUNOBLOTTING; IN VIVO STUDY; LYMPHOCYTE SUBPOPULATION; MONOCYTE; OXYGEN TENSION; PHAGOCYTOSIS; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RNA INTERFERENCE; T LYMPHOCYTE; ANOXIA; BIOLOGICAL MODEL; CELL CULTURE; CELL MOTION; CELL PROLIFERATION; CULTURE TECHNIQUE; DRUG EFFECT; FLOW CYTOMETRY; GENETICS; IMMUNOLOGY; METABOLISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANOXIA; ANTIGEN PRESENTATION; ANTIGENS, CD; CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; DENDRITIC CELLS; FLOW CYTOMETRY; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; IMMUNOBLOTTING; IMMUNOGLOBULINS; INTERLEUKIN-4; LIPOPOLYSACCHARIDES; MEMBRANE GLYCOPROTEINS; MODELS, IMMUNOLOGICAL; MONOCYTES; OXYGEN; PHAGOCYTOSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; T-LYMPHOCYTES;

EID: 84860820354     PISSN: 03407004     EISSN: 14320851     Source Type: Journal    
DOI: 10.1007/s00262-011-1112-5     Document Type: Article

References (36)

1. Galy A, Travis M, Cen D, Chen B (1995) Human T, B, natural killer, and dendritic cells arise from a common bone marrow progenitor cell subset. Immunity 3(4):459-473
2. Randolph GJ, Inaba K, Robbiani DF, Steinman RM, Muller WA (1999) Differentiation of phagocytic monocytes into lymph node dendritic cells in vivo. Immunity 11(6):753-761 (Pubitemid 30030714)
3. Caldwell CC, Kojima H, Lukashev D, Sitkovsky MV et al (2001) Differential effects of physiologically relevant hypoxic conditions on T lymphocyte development and effector functions. J Immunol 167(11):6140-6149 (Pubitemid 33081540)
4. Hockel S, Schlenger K, Vaupel P, Hockel M (2001) Association between host tissue vascularity and the prognostically relevant tumor vascularity in human cervical cancer. Int J Oncol 19(4):827-832
5. Sallusto F, Lanzavecchia A (1994) Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/ macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J Exp Med 179(4):1109-1118
6. Cella M, Sallusto F, Lanzavecchia A (1997) Origin, maturation and antigen presenting function of dendritic cells. Curr Opin Immunol 9(1):10-16 (Pubitemid 27095893)
7. Soruri A, Zwirner J (2005) Dendritic cells: limited potential in immunotherapy. Int J Biochem Cell Biol 37(2):241-245 (Pubitemid 39330183)
8. Banchereau J, Steinman RM (1998) Dendritic cells and the control of immunity. Nature 392(6673):245-252 (Pubitemid 28155090)
9. Thomas R, Chambers M, Boytar R, Andersen J et al (1999) Immature human monocyte-derived dendritic cells migrate rapidly to draining lymph nodes after intradermal injection for melanoma immunotherapy. Melanoma Res 9(5):474-481 (Pubitemid 29494113)
10. Banchereau J, Briere F, Caux C, Palucka K et al (2000) Immunobiology of dendritic cells. Annu Rev Immunol 18:767-811 (Pubitemid 30365397)
11. Zinkernagel AS, Johnson RS, Nizet V (2007) Hypoxia inducible factor (HIF) function in innate immunity and infection. J Mol Med 85(12):1339-1346 (Pubitemid 350234101)
12. Gale DP, Maxwell PH (2009) The role of HIF in immunity. Int J Biochem Cell Biol 42(4):486-494
13. Mancino A, Schioppa T, Larghi P, Sica A et al (2008) Divergent effects of hypoxia on dendritic cell functions. Blood 112(9): 3723-3734
14. Bosco MC, Pierobon D, Blengio F, Varesio L et al (2009) Hypoxia modulates the gene expression profile of immunoregulatory receptors in human mDCs: identification of TREM-1 as a novel hypoxic marker in vitro and in vivo. Blood 117(9):2625-2639
15. Bosco MC, Puppo M, Blengio F, Varesio L et al (2008) Monocytes and dendritic cells in a hypoxic environment: spotlights on chemotaxis and migration. Immunobiology 213(9-10):733-749
16. Tasaki A, Yamanaka N, Kubo M, Katano M et al (2004) Three-dimensional two-layer collagen matrix gel culture model for evaluating complex biological functions of monocyte-derived dendritic cells. J Immunol Methods 287(1-2):79-90 (Pubitemid 38510210)
17. Kim JB (2005) Three-dimensional tissue culture models in cancer biology. Semin Cancer Biol 15(5):365-377
18. Onishi H, Kuroki H, Katano M, Morisaki T et al (2004) Monocyte-derived dendritic cells that capture dead tumor cells secrete IL-12 and TNF-alpha through IL-12/TNF-alpha/NF-kappaB autocrine loop. Cancer Immunol Immunother 53(12):1093-1100 (Pubitemid 39506398)
19. Onishi H, Morisaki T, Kuroki H, Katano M et al (2005) Evaluation of a dysfunctional and short-lived subset of monocytederived dendritic cells from cancer patients. Anticancer Res 25(5):3445-3451 (Pubitemid 41105223)
20. Qu X, Yang MX, Kong BH, Lu L et al (2005) Hypoxia inhibits the migratory capacity of human monocyte-derived dendritic cells. Immunol Cell Biol 83(6):668-673 (Pubitemid 43083099)
21. Ricciardi A, Elia AR, Cappello P, Varesio L et al (2008) Transcriptome of hypoxic immature dendritic cells: modulation of chemokine/receptor expression. Mol Cancer Res 6(2):175-185 (Pubitemid 351342405)
22. Zhao W, Darmanin S, Fu Q, Chen J, Kobayashi M et al (2005) Hypoxia suppresses the production of matrix metalloproteinases and the migration of human monocyte-derived dendritic cells. Eur J Immunol 35(12):3468-3477 (Pubitemid 43025528)
23. Zhao P, Li XG, Yang M, Qu X et al (2008) Hypoxia suppresses the production of MMP-9 by human monocyte-derived dendritic cells and requires activation of adenosine receptor A2b via cAMP/PKA signaling pathway. Mol Immunol 45(8):2187-2195
24. Du R, Lu KV, Petritsch C, Bergers G et al (2008) HIF1alpha induces the recruitment of bone marrow-derived vascular modulatory cells to regulate tumor angiogenesis and invasion. Cancer Cell 13(3):206-220 (Pubitemid 351318372)
25. Faveeuw C, Preece G, Ager A (2001) Transendothelial migration of lymphocytes across high endothelial venules into lymph nodes is affected by metalloproteinases. Blood 98(3):688-695
26. Elia AR, Cappello P, Puppo M, Giovarelli M et al (2008) Human dendritic cells differentiated in hypoxia down-modulate antigen uptake and change their chemokine expression profile. J Leukoc Biol 84(6):1472-1482 (Pubitemid 352774482)
27. Nam EH, Park SR, Kim PH (2010) TGF-beta1 induces mouse dendritic cells to express VEGF and its receptor (Flt-1) under hypoxic conditions. Exp Mol Med 42(9):606-613
28. Riboldi E, Musso T, Moroni E, Sozzani S et al (2005) Cutting edge: proangiogenic properties of alternatively activated dendritic cells. J Immunol 175(5):2788-2792 (Pubitemid 41170494)
29. Gabrilovich DI, Chen HL, Girgis KR, Carbone DP et al (1996) Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells. Nat Med 2(10):1096-1103 (Pubitemid 26338628)
30. Gabrilovich D, Ishida T, Oyama T, Carbone DP et al (1998) Vascular endothelial growth factor inhibits the development of dendritic cells and dramatically affects the differentiation of multiple hematopoietic lineages in vivo. Blood 92(11):4150-4166 (Pubitemid 28544331)
31. Alfaro C, Suarez N, Gonzalez A, Perez-Gracia JL et al (2009) Influence of bevacizumab, sunitinib and sorafenib as single agents or in combination on the inhibitory effects of VEGF on human dendritic cell differentiation from monocytes. Br J Cancer 100(7):1111-1119
32. Hirano N, Butler MO, Xia Z, Nadler LM et al (2006) Engagement of CD83 ligand induces prolonged expansion of CD8 + T cells and preferential enrichment for antigen specificity. Blood 107(4):1528-1536 (Pubitemid 43242391)
33. Aerts-Toegaert C, Heirman C, Tuyaerts S, Breckpot K et al (2007) CD83 expression on dendritic cells and T cells: correlation with effective immune responses. Eur J Immunol 37(3):686-695 (Pubitemid 46916935)
34. Zhou LJ, Tedder TF (1995) Human blood dendritic cells selectively express CD83, a member of the immunoglobulin superfamily. J Immunol 154(8):3821-3835
35. Prechtel AT, Turza NM, Theodoridis AA, Steinkasserer A (2007) CD83 knockdown in monocyte-derived dendritic cells by small interfering RNA leads to a diminished T cell stimulation. J Immunol 178(9):5454-5464 (Pubitemid 46674339)
36. Kuga H, Morisaki T, Nakamura K, Katano M et al (2003) Interferon-gamma suppresses transforming growth factor-beta-induced invasion of gastric carcinoma cells through cross-talk of Smad pathway in a three-dimensional culture model. Oncogene 22(49):7838-7847 (Pubitemid 37485543)